Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus

NCT01405196 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
183
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer